Troglitazone 5mg | ≥98%
CSNpharm
Troglitazone is a PPARγ agonist with EC50 of 780 nM in murine and 555 nM in human. It has no activity at PPARα or PPARδ and can act as an anti-diabetic agent.
More Information Supplier Page
Troglitazone is a PPARγ agonist with EC50 of 780 nM in murine and 555 nM in human. It has no activity at PPARα or PPARδ and can act as an anti-diabetic agent.
More Information Supplier Page
Troglitazone is a PPARγ agonist with EC50 of 780 nM in murine and 555 nM in human. It has no activity at PPARα or PPARδ and can act as an anti-diabetic agent.
More Information Supplier Page
Trimebutine is an agonist effect on peripheral μ, k and δ opiate receptors, and also shows antimuscarinic effect.
More Information Supplier Page
Trimebutine is an agonist effect on peripheral μ, k and δ opiate receptors, and also shows antimuscarinic effect.
More Information Supplier Page
Tolfenamic acid is a selective COX2 inhibitor with IC50 of 13.49 μM, it’s a non-steroidal anti-inflammatory drugs (NSAIDs).
More Information Supplier Page
Tolfenamic acid is a selective COX2 inhibitor with IC50 of 13.49 μM, it’s a non-steroidal anti-inflammatory drugs (NSAIDs).
More Information Supplier Page
Tolbutamide is a potassium channel blocker, sulfonylurea oral hypoglycemic drug.
More Information Supplier Page
Tolbutamide is a potassium channel blocker, sulfonylurea oral hypoglycemic drug.
More Information Supplier Page
Tolazamide is an intermediate-acting, first-generation sulfonylurea with hypoglycemic activity.
More Information Supplier Page
Tolazamide is an intermediate-acting, first-generation sulfonylurea with hypoglycemic activity.
More Information Supplier Page